By now, you’ve probably heard that the maker of the European emergency contraception pill NorLevo has changed its labeling to indicate that it is not effective in women weighing more than 80kg (176 pounds), and that it’s less effective in women who weigh 75 kg (165 pounds) or more.

What you may not have heard is that the NorLevo label was also updated to reflect the current scientific consensus on its method of action. The label now reads:

NorLevo works by stopping your ovaries from releasing an egg. It cannot stop a fertilized egg from attaching to the womb.

NorLevo is identical to Plan B One-Step, which is sold in the United States. The FDA should allow the manufacturers of Plan B, NextChoice, and other levonorgestrel emergency contraceptive pills to bring their labels up to date as well.

Our fact sheet, Emergency Contraception: The Facts Every Pro-Life Advocate Should Know, has been updated to include the news about NorLevo. Please share it with pro-lifers who are concerned about the possibility of emergency contraception acting as an abortifacient.

Bookmark and Share

Comments

  1. Once again, All Our Lives is the most sensible when it comes to contraception. Thank you!